Overview: ESSA Pharma Inc. is a clinical-stage pharmaceutical company dedicated to developing small molecule drugs for prostate cancer treatment, with a market cap of $79.86 million. Operations: ESSA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback